Home    About Us    Medic-All    Bio B2B    Hot Topic     Expo     Login | Join Now          
Bio B2BTAHO Pharmaceuticals Ltd. 〉TAH4411 Antiemetic Oral Thin Film

TAH4411 Antiemetic Oral Thin Film

TAH4411 Antiemetic Oral Thin Film

Oral dissolving film (ODF) of cancer therapy induced nausea and vomiting (CINV)

Request for Collaboration
Overview
TAH4411 oral dissolving film (ODF) is a new formulation of a selective 5-HT3 receptor antagonist which blocks stimulation on both peripherally located vagal nerve terminals and centrally located receptors in the chemoreceptor trigger zone of the area postrema.

This new formulation provides equivalent amount of the active ingredient as in Zofran® tablets and Zofran® OD tablets, but with a potential of better acceptance in by patients who are less tolerant of swallowing tablets.
Collaboration Options
We are seeking to out-license TAH4411 to a pharmaceutical company with suitable sales and marketing in US and Japan.
People who like this also like
  • FB825FB825
  • Stabilized Injectable Formulation - SIFStabilized Injectable Formulation - SIF
  • FB825FB825
  • PHDC-01PHDC-01
  • Cell selection adhesion technologyCell selection adhesion technology
  • TLC399TLC399
  • Non-invasive Fiber Optic Physiological Monitoring TechnologyNon-invasive Fiber Optic Physiological Monitoring Technology
  • Homogeneous antibody drugs (CHO-H01, H02, H03)Homogeneous antibody drugs (CHO-H01, H02, H03)
  • RT-PCR BIO-CHIPRT-PCR BIO-CHIP
  • TLC388TLC388